Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia - No Study Results Posted

Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia (GFMVOR2007)

This study has been completed.

Study NCT00776503 Information provided by Groupe Francophone des Myelodysplasies

First Received: October 20, 2008 Last Updated: November 25, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	November 2011
Primary Completion Date:	November 2011 (Final data collection date for primary outcome measure)